Tirbanibulin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Tirbanibulin. Educational only — not medical advice.
Labeled uses
KLISYRI is indicated for the topical field treatment of actinic keratosis on the face or scalp.
Source: FDA labeling via NIH DailyMed (set 589c8de8…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.